Biotherapy for metastatic endocrine tumours
- 31 August 2005
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 19 (4) , 617-636
- https://doi.org/10.1016/j.bpg.2005.02.012
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Fluvoxamine Treatment of Major Depression Associated With Multiple SclerosisThe Journal of Neuropsychiatry and Clinical Neurosciences, 2004
- Interferon in the Management of Neuroendocrine GEP-TumorsDigestion, 2000
- Treatment of the carcinoid syndrome with a depot formulation of the somatostatin analogue lanreotideEuropean Journal Of Cancer, 1994
- Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumoursEuropean Journal Of Cancer, 1992
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- Treatment of metastatic carcinoid tumour with recombinant interferon alfaEuropean Journal Of Cancer, 1992
- The role of interferons in the management of carcinoid tumoursBritish Journal of Haematology, 1991
- Treatment of Malignant Midgut Carcinoid Tumours with A Long-Acting Somatostatin Analogue OctreotideActa Oncologica, 1991
- RESISTANCE OF METASTATIC PANCREATIC ENDOCRINE TUMOURS AFTER LONG‐TERM TREATMENT WITH THE SOMATOSTATIN ANALOGUE OCTREOTIDE (SMS 201–995)Clinical Endocrinology, 1989
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982